Inrevila - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 28,327 | 28,907 | 29,110 | 46,598 | 50,525 | 63,924 | 61,610 | 62,370 |
| Profit before tax | 494 | 1,597 | 11,486 | - | 4,174 | 3,001 | 2,217 | 2,955 |
| Net profit | 494 | 1,357 | 11,486 | 1,894 | 4,174 | 3,001 | 1,884 | 2,513 |
| Equity | -507 | 1,090 | 12,576 | 14,470 | 18,644 | 21,645 | 23,214 | 24,285 |
| Liabilities | 2,888 | 2,552 | 1,466 | 10,034 | 5,420 | 6,035 | 1,492 | 0 |
| Non-current assets | 686 | 682 | 7,625 | 18,660 | 20,706 | 21,388 | 20,783 | 15,001 |
| Current assets | 1,695 | 2,960 | 6,417 | 5,844 | 3,358 | 6,292 | 3,923 | 9,284 |
| Total assets | 2,381 | 3,642 | 14,042 | 24,504 | 24,064 | 27,680 | 24,706 | 24,285 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 6,433 | 6,794 | 7,201 |
|
Financial indicators
|
||||||||
| Revenue change y/y | -5.5% | +2.0% | +0.7% | +60.1% | +8.4% | +26.5% | -3.6% | +1.2% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 20.7% | 37.3% | 81.8% | 7.7% | 17.3% | 10.8% | 7.6% | 10.3% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | 124.5% | 91.3% | 13.1% | 22.4% | 13.9% | 8.1% | 10.3% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 1.7% | 4.7% | 39.5% | 4.1% | 8.3% | 4.7% | 3.1% | 4.0% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 1.7% | 5.5% | 39.5% | - | 8.3% | 4.7% | 3.6% | 4.7% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | 2.3 | 0.1 | 0.7 | 0.3 | 0.3 | 0.1 | - |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 14,164 | 14,454 | 14,555 | 16,447 | 20,907 | 21,308 | 20,537 | 20,790 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Inrevila - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2024-07-16 | 2024-07-18 | 368.89 |
| 2024-05-16 | 2024-05-26 | 368.89 |
| 2022-04-19 | 2022-05-16 | 13.51 |
| 2022-03-16 | 2022-04-13 | 65.51 |
| 2022-02-17 | 2022-03-14 | 117.51 |
| 2022-01-18 | 2022-02-13 | 169.51 |
| 2021-12-22 | 2022-01-16 | 152.58 |
| 2021-12-21 | 2021-12-21 | 663.12 |
| 2021-12-16 | 2021-12-20 | 663.12 |
| 2021-11-23 | 2021-12-15 | 204.58 |
| 2021-11-17 | 2021-11-22 | 204.58 |
| 2021-11-16 | 2021-11-16 | 706.80 |
| 2021-11-08 | 2021-11-15 | 204.58 |
| 2021-11-05 | 2021-11-07 | 204.12 |
| 2021-10-25 | 2021-11-04 | 308.12 |
| 2021-10-18 | 2021-10-24 | 308.12 |
| 2021-09-16 | 2021-10-12 | 308.12 |
Inrevila - VMI tax arrears
As of 2026-09-02, the amount of overdue STI tax debt of the company Inrevila is: 1 €
| From | To | Overdue, € |
|---|---|---|
| 2026-06-30 | 2026-09-02 | 1.47 |
| 2026-06-18 | 2026-06-29 | 1.59 |
| 2026-02-03 | 2026-02-03 | 1.8 |
| 2025-12-22 | 2026-01-12 | 3.8 |
| 2025-12-20 | 2025-12-21 | 1.95 |
| 2025-12-17 | 2025-12-19 | 8.1 |
| 2025-12-15 | 2025-12-16 | 585.86 |
| 2025-12-01 | 2025-12-14 | 8.1 |
| 2025-11-02 | 2025-11-30 | 3.9 |
| 2025-10-02 | 2025-11-01 | 7.96 |
| 2025-09-30 | 2025-10-01 | 6.31 |
| 2025-09-12 | 2025-09-29 | 4.36 |
| 2025-09-07 | 2025-09-11 | 582.12 |
| 2025-08-27 | 2025-09-06 | 4.36 |
| 2025-08-13 | 2025-08-26 | 0.09 |
| 2025-08-01 | 2025-08-12 | 4.09 |
| 2025-07-31 | 2025-07-31 | 1.85 |
| 2025-07-15 | 2025-07-30 | 0.09 |
| 2025-06-26 | 2025-07-14 | 2.61 |
| 2025-06-17 | 2025-06-25 | 2.52 |
| 2025-05-20 | 2025-06-12 | 4.48 |
| 2025-05-01 | 2025-05-13 | 2.04 |
| 2025-04-30 | 2025-04-30 | 1.24 |
| 2025-02-20 | 2025-03-12 | 0.62 |
| 2025-02-18 | 2025-02-19 | 0.3 |
| 2025-02-17 | 2025-02-17 | 618.68 |
| 2025-02-16 | 2025-02-16 | 616.43 |
| 2025-02-15 | 2025-02-15 | 547.48 |
| 2025-02-14 | 2025-02-14 | 4.65 |
| 2025-01-15 | 2025-02-13 | 3.24 |
| 2025-01-14 | 2025-01-14 | 598.6 |
| 2025-01-10 | 2025-01-13 | 1.0 |
| 2024-12-17 | 2025-01-09 | 5.48 |
| 2024-12-15 | 2024-12-16 | 593.67 |
| 2024-12-14 | 2024-12-14 | 591.59 |
| 2024-09-26 | 2024-12-13 | 1.0 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Inrevila, UAB (code 152846472) is a private limited liability company engaged in medical specialists activities. In 2025, the company generated revenue of €62.4K and net profit of €2.5K, corresponding to a profit margin of 4.0%. Revenue increased by 1.2% year on year, while the two-year change was -2.4%, showing broadly stable turnover after a slight decline in 2024. The multi-year trajectory shows revenue of €63.9K and net profit of €3.0K in 2023, followed by €61.6K revenue and €1.9K profit in 2024, and then a moderate recovery in 2025. At year-end 2025, total assets were €24.3K, matching equity at €24.3K, while liabilities were €1.5K, indicating a very strong capital structure. Long-term assets amounted to €15.0K and short-term assets to €9.3K. Key ratios remained solid, with ROE at 10.3%, ROA at 10.3%, and asset turnover at 2.57x. Revenue per employee was €20.8K and profit per employee was €838.